OPTHHealthcare · Drug Manufacturers - Specialty & Generic

OPTH Stock Forecast: Optimi Health Corp. Price Predictions for 2026-2027

Last close, 24 Aug 2026

$4.98

−0.40% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 15 of 100 as at 22 Aug 2026 — in the weakest quartile.

Market cap

$28.6M

Ticker Nerd rank

15 / 100

Median analyst target

—

Analysts covering

—

Revenue$100K+62.5% y/y

Operating income−$1.4M

Net income−$1.6M

Free cash flow−$345K

Quarterly, 5 quarters to 31 Mar 2026 · latest quarter's figure shown

Total return, dividends reinvested

+4.4%

+6.4%

From high

−18.1%

From low

+24.2%

$4.01

$6.08

Range since 20 May 2026, adjusted closes · the dot is the last close

Ticker Nerd rank

OPTH stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Optimi Health Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026

15 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size

Revisions

Volatility

Momentum

Value

Growth

Accruals

Quality

Issuance

Size (87): Smaller than most of the companies we track.

Issuance (3): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

OPTH stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on OPTH, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, since 20 May 2026Adjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. OPTH appears on the weeks it earns a place.

Performance

OPTH vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

OPTH vs S&P 500, last 12 monthsTotal return, rebased to 100

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

OPTH analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year

Analysts raising

Analysts cutting

Fundamentals

Optimi Health Corp. (OPTH) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: −4.2×
Price / sales: 163.0×
Price / book: 1.7×
EV / EBITDA: −4.9×

Growth & margins

Revenue growth (YoY): −28.6%
Earnings growth (YoY): 62.5%
Gross margin: 89.9%
Operating margin: −957.8%
Net margin: −16.0%

Returns & dividend

Return on equity: −54.4%
Return on assets: −16.1%
Dividend yield: —

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Optimi Health Corp. (OPTH) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

Optimi Health Corp. has a market value of $28.6M and an enterprise value of $15.0M.
Revenue in the twelve months to 31 Mar 2026: $232K. The latest quarter shrank 28.6% year on year.
Net income over the same four quarters: −$5.4M, a −2330.1% net margin.
Free cash flow in the twelve months to 31 Mar 2026: −$3.3M, after $88K of capital spending.
Shares outstanding: 3.2M.
Trailing P/E: −4.2×.
Optimi Health Corp. employs 6 people — $39K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 31 Mar 2026 · market figures as at 24 Aug 2026

Data provided by Twelve Data

Peers

OPTH vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelDrug Manufacturers - Specialty & Generic

Company	Market cap	TKN rank
OPTHOptimi Health Corp.	$28.6M	15
UPCUniverse Pharmaceuticals, Inc.	$26.6M	30
AYTUAytu Biopharma, Inc.	$25.4M	62
BTAIBioXcel Therapeutics, Inc.	$24.8M	31
TXMDTherapeuticsMD, Inc.	$23.8M	79
RMTIRockwell Medical, Inc.	$32.0M	49
BFRIBiofrontera, Inc.	$22.0M	66

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Optimi Health Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest OPTH news & analysis

Optimi Health Establishes Discretionary Equity Facility

GlobeNewsWire · 14 Aug 2026neutral

Optimi Health Corp. announced it entered into a common shares purchase agreement with Seven Knots, LLC, establishing a discretionary equity line of credit under which the Company has the right, but not the obligation, to sell up to US$100 million of its common shares over the term of the facility.

Why it matters — This facility gives Optimi access to potential financing of up to US$100 million on a discretionary basis, which watchers may see as relevant to the company's capital-raising flexibility and liquidity.

FAQ

Frequently asked questions about OPTH stock

How does Ticker Nerd's model rank OPTH?

As at 22 Aug 2026, Optimi Health Corp. ranks 15 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (87 of 100).

What is the OPTH stock forecast for 2030?

No analyst covering Optimi Health Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for OPTH are extrapolating price history, which says nothing about the business.

What does Optimi Health Corp. do?

Optimi Health Corp. is a commercial-stage pharmaceutical company focused on the manufacturing and distribution of regulated psychedelic drug products.

What is the latest news on OPTH?

The most recent item we track (GlobeNewsWire, 14 Aug 2026): "Optimi Health Establishes Discretionary Equity Facility". Optimi Health Corp. announced it entered into a common shares purchase agreement with Seven Knots, LLC, establishing a discretionary equity line of credit under which the Company has the right, but not the obligation, to sell up to US$100 million of its common shares over the term of the facility.

Company

About Optimi Health Corp.

Optimi Health Corp. is a commercial-stage pharmaceutical company focused on the manufacturing and distribution of regulated psychedelic drug products. The company produces finished-dose psilocybin and MDMA capsules, along with active pharmaceutical ingredients, at a Health Canada-licensed, GMP-compliant facility in British Columbia. Its products are supplied to authorized clinical and therapeutic programs, supporting patient access through regulated channels in markets such as Australia and Canada. Optimi Health Corp. serves the growing mental health treatment ecosystem by providing standardized drug products for psychiatrists, clinics, and research programs that require controlled, pharmaceutical-grade supply. The company also develops related product formats within its licensed manufacturing platform, reinforcing its role as a specialized supplier in the pharmaceutical and life sciences sectors.

CEO Mr. Dane Stevens · 6 employees · Canada · https://www.optimihealth.ca